These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7906568)

  • 21. [Importance of introduction of PCR in blood banks].
    Gürtler L
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):4-6. PubMed ID: 8653016
    [No Abstract]   [Full Text] [Related]  

  • 22. [Infections as complications of blood transfusion]].
    Kłos M
    Przegl Epidemiol; 2001; 55 Suppl 3():4-9. PubMed ID: 11984956
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfusion-transmitted viruses.
    Wright-Kanuth MS; Smith LA
    Clin Lab Sci; 2003; 16(4):221-9. PubMed ID: 14626440
    [No Abstract]   [Full Text] [Related]  

  • 24. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The risk of substitution therapy with blood and blood products].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136
    [No Abstract]   [Full Text] [Related]  

  • 26. [Post-transfusion viral hepatitis].
    Katayama T
    Rinsho Byori; 1991 Mar; Suppl 88():156-70. PubMed ID: 1906949
    [No Abstract]   [Full Text] [Related]  

  • 27. [Procedure of Look Back (pursuant to 19 Transfusion Law). At the 62nd meeting of the Work Group Blood on June 14, 2006 the following vote (V 34) was passed].
    Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):940-57. PubMed ID: 16953363
    [No Abstract]   [Full Text] [Related]  

  • 28. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.
    Kleinman S; Busch MP; Korelitz JJ; Schreiber GB
    Transfus Med Rev; 1997 Jul; 11(3):155-72. PubMed ID: 9243769
    [No Abstract]   [Full Text] [Related]  

  • 29. [The actual risk of retrovirus transmission from transfusions].
    Soriano V; Mas A
    Sangre (Barc); 1995 Oct; 40(5):407-16. PubMed ID: 8553176
    [No Abstract]   [Full Text] [Related]  

  • 30. [Infection risk caused by blood or blood products].
    Gürtler L; Schramm W
    Dtsch Med Wochenschr; 1993 Apr; 118(14):520-2. PubMed ID: 7741799
    [No Abstract]   [Full Text] [Related]  

  • 31. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk of infection in hemotherapy].
    Sibrowski W; Wüllenweber J
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():60-3. PubMed ID: 8000255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic transfusion hepatitis--an underestimated disease].
    Henschel M; Kilburg M; Feurle GE
    Med Klin (Munich); 1996 Jul; 91(7):438-41. PubMed ID: 8756110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
    Chandra T; Kumar A; Gupta A
    Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of blood components and derivatives.
    Julius C; Westphal RG
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS risk minimal after blood transfusion.
    Todays OR Nurse; 1993; 15(1):60-1. PubMed ID: 8096098
    [No Abstract]   [Full Text] [Related]  

  • 37. The risks of transfusion-transmitted infection: direct estimation and mathematical modelling.
    Kleinman SH; Busch MP
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):631-49. PubMed ID: 11102281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing transfusion-transmitted infections: issues related to migrating populations and increasing world travel.
    Sandler SG; Fang C
    Haematologia (Budap); 1991; 24(4):197-210. PubMed ID: 1688227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso.
    Kania D; Sangaré L; Sakandé J; Koanda A; Nébié YK; Zerbo O; Combasséré AW; Guissou IP; Rouet F
    Transfusion; 2009 Oct; 49(10):2237-40. PubMed ID: 19903285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.